December 13, 2021 07:23 AM ESTUpdated 07:36 AM
Coronavirus

Covid-19 roundup: French reg­u­la­tors not ready to give mol­nupi­ravir the OK; Brii claims Chi­na’s first an­ti­body is ef­fec­tive against Omi­cron

Josh Sullivan

Mer­ck’s po­ten­tial Covid-19 treat­ment mol­nupi­ravir will not be used in France, French reg­u­la­tors said Fri­day.

The French Na­tion­al Au­thor­i­ty of Health …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Out­look's shares crash as wet AMD drug flunks Phase 3 test

A service from the Financial Times